Skip to Main Content

Author Details

Cristina Ivan
The University of Texas MD Anderson Cancer Center
2010
196
57
PMIDPaper TitleJournal TitlePublished Year
37261908Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response.J Clin Invest2023
37940695Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer.Cell Discov2023
37921671Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.Oncotarget2023
37217493The deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs.Cell Death Dis2023
3725296917β-estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer.Proc Natl Acad Sci U S A2023
37100807Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.Nat Commun2023
34772589CORRIGENDUM: GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.Cell Signal2022
35642638SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers.J Clin Invest2022
35625973lncRNAs UC.145 and PRKG1-AS1 Determine the Functional Output of DKK1 in Regulating the Wnt Signaling Pathway in Gastric Cancer.Cancers (Basel)2022
37152770Long noncoding RNA 01534 maintains cancer stemness by downregulating endoplasmic reticulum stress response in colorectal cancer.Ann Gastroenterol Surg2022
35914489Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304].EBioMedicine2022
36077759Contributions of Circulating microRNAs for Early Detection of Lung Cancer.Cancers (Basel)2022
35000145Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer.Pharmacol Rep2022
35204715Transcribed Ultraconserved Regions Are Associated with Clinicopathological Features in Breast Cancer.Biomolecules2022
35326647Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer.Cancers (Basel)2022
35259043Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia.Leuk Lymphoma2022
33149280The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis.Oncogene2021
33793425Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens.JCI Insight2021
33793423Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.JCI Insight2021
33792569ATP11B mediates platinum resistance in ovarian cancer.J Clin Invest2021
33567287Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype.Cell Rep2021
33668685PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway.Int J Mol Sci2021
33614241ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer.Mol Ther Nucleic Acids2021
35036070Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome.Mol Ther Nucleic Acids2021
34433970Author Correction: TP53 loss creates therapeutic vulnerability in colorectal cancer.Nature2021
34583979Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models.Mol Cancer Ther2021
34391578MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer.Gynecol Oncol2021
34593619Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer.J Immunother Cancer2021
34387142A novel lncRNA derived from an ultraconserved region: lnc-<i>uc.147</i>, a potential biomarker in luminal A breast cancer.RNA Biol2021
34156971miRNAs generated from Meg3-Mirg locus are downregulated during aging.Aging (Albany NY)2021
34348992Gene Body Methylation of the Lymphocyte-Specific Gene <i>CARD11</i> Results in Its Overexpression and Regulates Cancer mTOR Signaling.Mol Cancer Res2021
34298668Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast Cancer.Cancers (Basel)2021
33988982Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity.J Am Chem Soc2021
31124563Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.J Natl Cancer Inst2020
31935430GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.Cell Signal2020
31908025KRCC1: A potential therapeutic target in ovarian cancer.FASEB J2020
31963578The Long Non-Coding RNA <i>Prader Willi/Angelman Region RNA5</i> (<i>PAR5</i>) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity.Cancers (Basel)2020
32051587Loss of p53 drives neuron reprogramming in head and neck cancer.Nature2020
31988194Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.Gut2020
31941838miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.JCI Insight2020
31972470Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112].EBioMedicine2020
33033261Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy.Nat Commun2020
33159065Publisher Correction: Regulation of cellular sterol homeostasis by the oxygen responsive noncoding RNA lincNORS.Nat Commun2020
32977531FuncPEP: A Database of Functional Peptides Encoded by Non-Coding RNAs.Noncoding RNA2020
32973129Bone morphogenetic protein 7 promotes resistance to immunotherapy.Nat Commun2020
32917656Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype.Cancer Immunol Res2020
32805281The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.Gastroenterology2020
32958772Regulation of cellular sterol homeostasis by the oxygen responsive noncoding RNA lincNORS.Nat Commun2020
32754300Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer.Oncotarget2020
32340192Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer.Int J Mol Sci2020
  • 1 - 50 of 196

Recommended Authors

Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 3
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Pasqualino De Antonellis
University of Naples
Career Start Year 2010
Number of shared co-authors 3
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 1
Bo Gao
Crown Princess Mary Cancer Centre, Westmead Hospital
Career Start Year 2008
Number of shared co-authors 2
Ruby Yun-Ju Huang
National Taiwan University College of Medicine
Career Start Year 2008
Number of shared co-authors 3
Xiaoyong Huang
Medical College, Yan'an University
Career Start Year 2007
Number of shared co-authors 3
Rut Klinger
UCD Conway Institute, University College Dublin
Career Start Year 2006
Number of shared co-authors 0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 1
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 5
Liuqing Yang
University of Tennessee Health Science Center
Career Start Year 2004
Number of shared co-authors 8
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 2
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 2
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 24
Emiliano Dalla
University of Udine
Career Start Year 2002
Number of shared co-authors 1
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 4
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 13
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 1
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 2
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 5
Joanne B Weidhaas
University of California-Los Angeles
Career Start Year 2000
Number of shared co-authors 7
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 5
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 15
David Cogdell
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 13
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 10
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 5

Collaborators

Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers 79
Rajesha Rupaimoole
Harvard Medical School, Beth Israel Deaconess Medical Center
Co-authored papers 30
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers 20
Artem B Mamonov
MGH/Harvard Medical School
Co-authored papers 19
Rohit Varma
Southern California Eye Institute, CHA Hollywood Presbyterian Medical Center
Co-authored papers 19
Ramnik Singh
Co-authored papers 19
Marc Veldhoen
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Co-authored papers 17
Shannon Schreiner
Co-authored papers 16
Prahlad T Ram
Co-authored papers 15
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
Co-authored papers 14
Chad V Pecot
University of North Carolina at Chapel Hill
Co-authored papers 14
Mircea Ivan
Indiana University School of Medicine
Co-authored papers 10
Han Liang
MD Anderson Cancer Center
Co-authored papers 6
Wei Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Richard Platt
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 5
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Ondrej Slaby
Co-authored papers 5
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Pratip Bhattacharya
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Ramana V Davuluri
The Wistar Institute
Co-authored papers 4
Da Yang
Co-authored papers 4
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Mien-Chie Hung
Co-authored papers 3
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 3
Beate Rinner
Medical University of Graz
Co-authored papers 3
Jun Wei
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Co-authored papers 3
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Co-authored papers 3
James M Reuben
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Elizabeth Koch
University of Toronto
Co-authored papers 3
Release 1.2